Carillon System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation
Data was presented in a late-breaking trial session at the Cardiovascular Research Technologies meeting (CRT 2020) in National Harbor, MD.
Cardiac Dimensions Reaches 1,000 Implants Of Carillon System
Carillon Mitral Contour System® has been implanted in 1,000 patients in the United States, Europe, Australia, Turkey and the Middle East.
CARILLON Pivotal Trial Update: First Patient Randomized
9/19/18: “Current treatments to improve the quality of life for patients with FMR fall short and many heart failure patients are too frail for open-heart surgery,” said Samir Kapadia, M.D., interventional cardiologist and Cath Lab director at the Heart & Vascular Institute, Cleveland Clinic, and one of the principal investigators of the CARILLON Pivotal Trial.
